Clinical Trial Update: The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating the efficacy and safety of rosuvastatin plus ezetimibe versus rosuvastatin monotherapy in primary hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED